What's New
Calcium channel blockers and the possible risk of new-onset eczema
Medsafe is highlighting a possible risk of new-onset eczema with the use of calcium channel blockers (CCBs). The aim of this communication is to encourage further reporting to obtain more information on this potential safety concern.
News and Events
| Date | Type | Title |
|---|---|---|
| 11/4/2024 | Consultation | Outcome of the consultation on standards for contraceptive devices in New Zealand |
| 8/4/2024 | Alert Communication | Do not use NaturaCoco Moisturising Cream or Dok Apo Moisturiser Soothing Cream |
| 8/4/2024 | Monitoring Communication | Calcium channel blockers and the possible risk of new-onset eczema |
| 20/3/2024 | Consultation | Outcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Pharmacovigilance (medsafe.govt.nz) |
| 7/3/2024 | Publications | Prescriber Update Vol. 45. No. 1 - March 2024 |
| 4/3/2024 | Alert Communication | Recent cases of lead poisoning with Ayurvedic medicines |
| 29/2/2024 | Committees | Minutes of the 71st meeting of the Medicines Classification Committee - 14 November 202 |
